HALOZYME THERAPEUTICS, INC. Increase (Decrease) in Other Deferred Liability
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherDeferredLiability · last filed 2015-08-10
- HALOZYME THERAPEUTICS, INC. increase (decrease) in other deferred liability for the quarter ending 2015-06-30 was -$63.00K.
- HALOZYME THERAPEUTICS, INC. increase (decrease) in other deferred liability for the quarter ending 2015-03-31 was -$68.00K, a 193.15% decline year-over-year.
- HALOZYME THERAPEUTICS, INC. increase (decrease) in other deferred liability for the quarter ending 2014-09-30 was -$20.00K.
- HALOZYME THERAPEUTICS, INC. increase (decrease) in other deferred liability for the quarter ending 2014-06-30 was -$21.00K.
| Period end | Increase (Decrease) in Other Deferred Liability 3 month | Increase (Decrease) in Other Deferred Liability 6 month | Increase (Decrease) in Other Deferred Liability 6 month as first filed | Increase (Decrease) in Other Deferred Liability 9 month | Increase (Decrease) in Other Deferred Liability 9 month as first filed |
|---|---|---|---|---|---|
| 2015-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$131.00K 10-Q · filed 2015-08-10 | |||
| 2015-03-31 | -$68.00K 10-Q · filed 2015-05-11 | ||||
| 2014-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$41.00K derived: sum of 2 quarters · filed 2015-08-10 | $32.00K 10-Q · filed 2014-11-10 | ||
| 2014-06-30 | -$21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $52.00K 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | $73.00K 10-Q · filed 2015-05-11 | ||||
| 2013-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$82.00K derived: sum of 2 quarters · filed 2014-11-10 | -$39.00K 10-Q · filed 2014-11-10 | -$39.74K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $2.00K 10-Q · filed 2014-08-11 | $1.60K 10-Q · filed 2013-08-07 | ||
| 2013-03-31 | $43.00K 10-Q · filed 2014-05-12 | ||||
| 2012-09-30 | $2.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $62.38K 10-Q · filed 2013-11-08 | |||
| 2012-06-30 | $59.69K 10-Q · filed 2013-08-07 |